HINGE THERAPEUTICS Trademark

Trademark Overview

On Monday, April 10, 2017, a trademark application was filed for HINGE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the HINGE THERAPEUTICS trademark a serial number of 87983197. The federal status of this trademark filing is REGISTERED as of Tuesday, July 21, 2020. This trademark is owned by Hinge Therapeutics, Inc.. The HINGE THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

drug discovery services; pharmaceutical research and development, product research and development; research and development services for discovery and development of protein therapeutics, prophylactics, diagnostics, and theranostics for the treatment, prevention, palliation, and diagnosis of diseases; research of pharmaceutical products for the diagnosis of human disease or human health-related conditions; research of pharmaceutical products for the prevention or treatment of human diseases or human health-related conditions; development and design of pharmaceutical products for the diagnosis, prevention, or treatment of human diseases or human health-related conditions
hinge therapeutics

General Information

Serial Number87983197
Word MarkHINGE THERAPEUTICS
Filing DateMonday, April 10, 2017
Status700 - REGISTERED
Status DateTuesday, July 21, 2020
Registration Number6108444
Registration DateTuesday, July 21, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 12, 2017

Trademark Statements

Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and Servicesdrug discovery services; pharmaceutical research and development, product research and development; research and development services for discovery and development of protein therapeutics, prophylactics, diagnostics, and theranostics for the treatment, prevention, palliation, and diagnosis of diseases; research of pharmaceutical products for the diagnosis of human disease or human health-related conditions; research of pharmaceutical products for the prevention or treatment of human diseases or human health-related conditions; development and design of pharmaceutical products for the diagnosis, prevention, or treatment of human diseases or human health-related conditions

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, April 17, 2017
Primary Code042
First Use Anywhere DateWednesday, March 1, 2017
First Use In Commerce DateWednesday, March 1, 2017

Trademark Owner History

Party NameHinge Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSunnyvale, CA 94089
Party NameHinge Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSunnyvale, CA 94089
Party NameHinge Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSunnyvale, CA 94089

Trademark Events

Event DateEvent Description
Tuesday, January 16, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 16, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, January 16, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 16, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, January 16, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, July 21, 2020REGISTERED-PRINCIPAL REGISTER
Wednesday, June 17, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 16, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, June 10, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 9, 2020STATEMENT OF USE PROCESSING COMPLETE
Wednesday, May 27, 2020USE AMENDMENT FILED
Tuesday, June 9, 2020DIVISIONAL PROCESSING COMPLETE
Wednesday, May 27, 2020DIVISIONAL REQUEST RECEIVED
Tuesday, June 9, 2020SOU EXTENSION 5 GRANTED
Wednesday, May 27, 2020SOU EXTENSION 5 FILED
Monday, June 8, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, May 27, 2020TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, May 27, 2020SOU TEAS EXTENSION RECEIVED
Wednesday, May 27, 2020TEAS STATEMENT OF USE RECEIVED
Wednesday, February 5, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 3, 2020SOU EXTENSION 4 GRANTED
Monday, February 3, 2020SOU EXTENSION 4 FILED
Monday, February 3, 2020SOU TEAS EXTENSION RECEIVED
Thursday, July 18, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 16, 2019SOU EXTENSION 3 GRANTED
Tuesday, July 16, 2019SOU EXTENSION 3 FILED
Tuesday, July 16, 2019SOU TEAS EXTENSION RECEIVED
Friday, February 8, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 6, 2019SOU EXTENSION 2 GRANTED
Wednesday, February 6, 2019SOU EXTENSION 2 FILED
Wednesday, February 6, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, August 7, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, August 4, 2018SOU EXTENSION 1 GRANTED
Saturday, August 4, 2018SOU EXTENSION 1 FILED
Saturday, August 4, 2018SOU TEAS EXTENSION RECEIVED
Tuesday, February 6, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 12, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 12, 2017PUBLISHED FOR OPPOSITION
Wednesday, November 22, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, November 4, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, November 3, 2017ASSIGNED TO LIE
Monday, October 23, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 29, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 28, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 28, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 14, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 14, 2017NON-FINAL ACTION E-MAILED
Thursday, September 14, 2017NON-FINAL ACTION WRITTEN
Monday, August 28, 2017PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, August 8, 2017WITHDRAWN FROM PUB - OG REVIEW QUERY
Monday, July 10, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, July 8, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 7, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 7, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 30, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, June 30, 2017NON-FINAL ACTION E-MAILED
Friday, June 30, 2017NON-FINAL ACTION WRITTEN
Friday, June 30, 2017ASSIGNED TO EXAMINER
Monday, April 17, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 13, 2017NEW APPLICATION ENTERED

Related Keywords

therapeutics hinge human development research pharmaceutical diagnosis treatment products health prevention conditions